|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 213/74 | |
| C07D 213/75 | |||
| C07D 213/81 | |||
| C07D 213/82 | |||
| C07D 237/20 | |||
| C07D 239/42 | |||
| C07D 263/48 | |||
| C07D 277/42 | |||
| C07D 401/10 | |||
| C07D 401/12 | |||
| C07D 401/14 | |||
| C07D 405/12 | |||
| C07D 413/10 | |||
| C07D 413/12 | |||
| A61K 31/44 | |||
| A61K 31/50 | |||
| A61K 31/53 | |||
| A61K 31/421 | |||
| A61K 31/426 |
| (11) | Patento numeris | 2418202 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11158211.0 |
| Europos patento paraiškos padavimo data | 2007-03-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-02-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-01-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 787859 P | 2006-03-31 | US |
| (72) |
Serrano-Wu, Michael H, US
Kwak, Young-Shin, US
Liu, Wenming, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | (4-[4-[5-(substituted amino)-pyridin-2-yl]phenyl]-cyclohexyl)-acetic acid derivatives as DGAT inhibitors |
| (4-[4-[5-(substituted amino)-pyridin-2-yl]phenyl]-cyclohexyl)-acetic acid derivatives as DGAT inhibitors |